http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102276598-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D279-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D279-08
filingDate 2011-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2011-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102276598-A
titleOfInvention Benzothiazinethione derivatives and their preparation and use
abstract The invention belongs to the field of medicine, in particular to benzothiazinethione derivatives and their preparation methods and applications. The technical problem to be solved by the present invention is to provide a new class of benzothiazinethione derivatives, the structure of which is shown in formula I. The benzothiazinethione derivatives of the present invention are novel compounds obtained on the basis of a large number of screenings. compound, the experimental results show that the benzothiazinethione derivatives shown in formula I have obvious inhibitory effect on Mycobacterium tuberculosis, and the effect is equivalent to or even better than that of isoniazid (MIC 90 =0.8μM), and has anti-tuberculosis properties. Mycobacterium activity provides a new option for the development and application of anti-tuberculosis drugs.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104211708-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014014845-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104211708-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103508980-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013185507-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103508980-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9937192-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108456204-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9572809-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108456204-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114957232-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114957232-B
priorityDate 2011-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010286130-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009239851-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56971538
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413459360
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466544917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467935260

Total number of triples: 35.